Phase 2 Cancer Pain Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Not Yet Recruiting
Phase 2
Phase 2 Double-blind Placebo-controlled Multicenter Cross-over Study with Titration Period to Evaluate the Efficacy and Safety of IRX211a for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Breakthrough Cancer Pain
InhaleRx Ltd.156 enrolled1 locationACTRN12625000898459
Recruiting
Phase 1Phase 2
Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain
Cancer Pain
Shenyang Sunshine Pharmaceutical Co., LTD.132 enrolled1 locationNCT07008703
Not Yet Recruiting
Phase 2
Lidocaine (lignocaine) for Neuropathic Cancer Pain – Feasibility study (LiCPain)
Neuropathic Cancer Pain
University of Technology Sydney36 enrolled3 locationsACTRN12617000747325
Completed
Phase 2
A study comparing oxycodone to oxycodone/naloxone in moderate to severe, chronic cancer pain.
Moderate to severe chronic cancer pain.
Constipation.
Mundipharma Research GmbH & Co KG180 enrolled8 locationsACTRN12607000493448